A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
Public ClinicalTrials.gov record NCT06928142. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's
Study identification
- NCT ID
- NCT06928142
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Enrollment
- 83 participants
Conditions and interventions
Conditions
Interventions
- Sibeprenlimab Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 22, 2025
- Primary completion
- Mar 12, 2027
- Completion
- Jun 3, 2027
- Last update posted
- Mar 17, 2026
2025 – 2027
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medvin Clinical Research - Riverside | Riverside | California | 92508 | — |
| Medvin Clinical Research - Tujunga | Tujunga | California | 91042 | — |
| Bay Area Arthritis and Osteoporosis | Brandon | Florida | 33511 | — |
| Clinical Research of West Florida Inc | Clearwater | Florida | 33765 | — |
| GNP Research - Florida | Cooper City | Florida | 33024 | — |
| Vantage Clinical Trials - Tampa - ClinEdge - PPDS | Tampa | Florida | 33606 | — |
| OrthoIllinois, LTD | Rockford | Illinois | 61114-4937 | — |
| Arnold Arthritis and Rheumatology | Skokie | Illinois | 60076 | — |
| Ochsner Clinic Foundation | Baton Rouge | Louisiana | 70836 | — |
| Tufts University School of Dental Medicine | Boston | Massachusetts | 02111 | — |
| Albuquerque Center for Rheumatology | Albuquerque | New Mexico | 87102 | — |
| Bradenton Research Center Inc | The Bronx | New York | 34205-1704 | — |
| DJL Clinical Research PLLC | Charlotte | North Carolina | 28210 | — |
| STAT Research | Vandalia | Ohio | 45377 | — |
| Allen Arthritis | Allen | Texas | 75013 | — |
| Tekton Research, LLC | Austin | Texas | 78745 | — |
| Advanced Rheumatology of Houston | Houston | Texas | 77058 | — |
| Accurate Clinical Research - Houston | Houston | Texas | 77089 | — |
| Accurate Clinical Management, LLC | Katy | Texas | 77449 | — |
| R & H Clinical Research | Katy | Texas | 77450 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06928142, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06928142 live on ClinicalTrials.gov.